Trials / Completed
CompletedNCT01861535
Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy (defined as complete clinical response at 6 months) of imiquimod vs. standard treatment (surgery) for vulvar intraepithelial neoplasia (VIN).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imiquimod | |
| PROCEDURE | Surgery |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
- First posted
- 2013-05-23
- Last updated
- 2021-04-14
Locations
9 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT01861535. Inclusion in this directory is not an endorsement.